Is it safe to take cumin with rosuvastatin ( Crestor )?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cumin and Rosuvastatin Safety

There is no documented clinically significant interaction between cumin and rosuvastatin, making this combination safe for use.

Why This Combination Is Safe

The available evidence does not identify cumin as having any pharmacokinetic or pharmacodynamic interaction with rosuvastatin. The comprehensive American Heart Association guidelines on statin drug-drug interactions do not list cumin or common culinary spices as agents of concern 1.

Rosuvastatin's Favorable Interaction Profile

Rosuvastatin has several pharmacologic characteristics that minimize drug interaction risk:

  • Minimal CYP3A4 metabolism: Rosuvastatin undergoes only minor metabolism (approximately 10% of the administered dose) via CYP2C9, not CYP3A4, which is the enzyme responsible for most statin interactions 2, 3, 4

  • Hydrophilic and hepatoselective: These properties result in low systemic bioavailability and fewer systemic interactions compared to lipophilic statins 2, 5

  • Primary transport-mediated clearance: Rosuvastatin is mainly a substrate for OATP1B1/1B3 transporters rather than being extensively metabolized 2, 6

Documented Interactions to Actually Avoid

The agents that DO interact significantly with rosuvastatin are well-characterized and do not include cumin 1:

  • Cyclosporine: Causes 7-fold increase in rosuvastatin exposure; limit rosuvastatin to 5 mg daily 1
  • Gemfibrozil: Increases rosuvastatin levels and myopathy risk 2, 4
  • Antiretroviral agents: Particularly those containing pharmacokinetic enhancers 2
  • Warfarin: Requires monitoring of INR 2, 4

Standard Monitoring Applies

While cumin poses no specific concern, continue routine statin monitoring:

  • Monitor for muscle-related symptoms (myalgia, weakness) as with any statin therapy 2, 6
  • Baseline and periodic liver function tests as clinically indicated 2, 6
  • The overall incidence of myopathy with rosuvastatin is very low (≤0.1% at recommended doses) 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Rosuvastatin-associated adverse effects and drug-drug interactions in the clinical setting of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010

Research

Efficacy and safety of rosuvastatin in treatment of dyslipidemia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005

Research

Rosuvastatin: a review of its use in the management of dyslipidemia.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.